Hinge Health/$HNGE
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Hinge Health
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients. The Company's clients are self-insured employers.
Ticker
$HNGE
Sector
Primary listing
NYSE
Industry
Health Care Providers & Services
Headquarters
Employees
1,514
ISIN
US4333131039
Website
Hinge Health Metrics
BasicAdvanced
$3.7B
11.52
$4.07
-
-
Price and volume
Market cap
$3.7B
52-week high
$52.16
52-week low
$33.42
Average daily volume
944K
Financial strength
Current ratio
2.311
Quick ratio
2.044
Long term debt to equity
1.42
Total debt to equity
2.309
Profitability
EBITDA (TTM)
22.371
Gross margin (TTM)
79.46%
Net profit margin (TTM)
7.34%
Operating margin (TTM)
4.67%
Effective tax rate (TTM)
4.57%
Revenue per employee (TTM)
$290,000
Management effectiveness
Valuation
Price to earnings (TTM)
11.525
Price to revenue (TTM)
1.528
Price to book
-2.5
Price to tangible book (TTM)
-2.06
Price to free cash flow (TTM)
7.944
Free cash flow yield (TTM)
12.59%
Free cash flow per share (TTM)
590.98%
Growth
What the Analysts think about Hinge Health
Analyst ratings (Buy, Hold, Sell) for Hinge Health stock.
Bulls say / Bears say
Hinge Health's revenue climbed to $123.8 million in Q1 2025, marking a nearly 50% increase from the previous year, indicating strong growth momentum. (reuters.com)
The company reported a profit of $17 million in Q1 2025, reversing a prior loss, showcasing improved financial health. (reuters.com)
Hinge Health's IPO was priced at $32 per share, at the top end of the expected range, reflecting strong investor confidence. (cnbc.com)
Despite the IPO pricing, Hinge Health's valuation at $2.6 billion is significantly lower than its 2021 peak of $6.2 billion, indicating a substantial decrease in market valuation. (reuters.com)
The digital health sector has faced challenges post-Covid, with companies struggling to adapt to a muted growth environment, which could impact Hinge Health's future performance. (cnbc.com)
Hinge Health operates in a competitive market with rivals like Sword Health, which was valued at $3 billion in 2024, potentially affecting its market share and growth prospects. (benzinga.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jul 2025.
Hinge Health Financial Performance
Revenues and expenses
Hinge Health Earnings Performance
Company profitability
Hinge Health News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Hinge Health stock?
Hinge Health (HNGE) has a market cap of $3.7B as of July 17, 2025.
What is the P/E ratio for Hinge Health stock?
The price to earnings (P/E) ratio for Hinge Health (HNGE) stock is 11.52 as of July 17, 2025.
Does Hinge Health stock pay dividends?
No, Hinge Health (HNGE) stock does not pay dividends to its shareholders as of July 17, 2025.
When is the next Hinge Health dividend payment date?
Hinge Health (HNGE) stock does not pay dividends to its shareholders.
What is the beta indicator for Hinge Health?
Hinge Health (HNGE) does not currently have a Beta indicator.